Reltio
SEPTEMBER 13, 2022
Total Economic Impact™ Study Finds Reltio's Modern MDM Delivered 366% ROI. We recently commissioned Forrester Consulting to complete a study called "The Total Economic Impact™ (TEI) of the Reltio Master Data Management Platform , Cost Savings and Business Benefits Enabled by Reltio."
Adam Levin
MAY 7, 2020
The online credentials for 68% of pharmaceutical executives analyzed for a study have been compromised recently. The study, conducted by cybersecurity firm Blackcloak, found that the email accounts of over two-thirds of pharmaceutical executives had been compromised within the last five to ten years.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
erwin
MARCH 30, 2020
Privately it will come from hospitals, labs, pharmaceutical companies, doctors and private health insurers. To be successful and generate quality results, this consortium will need to adhere to strict disciplines around managing the data that comes into the study. Answering these questions is at the heart of data intelligence.
Security Affairs
JULY 5, 2023
The study is based on a total of 215 publicly reported incidents in the EU and neighboring countries. 42% of incidents reported targeted hospitals, while health authorities, bodies and agencies accounted for 14%, and the pharmaceutical industry for 9%. Most targeted assets (30%) are patient data, including electronic health records.
IBM Big Data Hub
AUGUST 7, 2023
Despite advancements in the pharmaceutical industry and biomedical research, delivering drugs to market is still a complex process with tremendous opportunity for improvement. The ability to seize these advantages is one way that pharmaceutical companies may be able to gain sizable competitive edge.
Schneier on Security
MAY 16, 2019
Studying this case, our experts found other samples that used similar algorithms. Also, our experts identified three additional victims: another video gaming company, a conglomerate holding company and a pharmaceutical company, all in South Korea. Now we learn that six other companies were targeted in the same operation.
Data Matters
JANUARY 27, 2020
The two cases concerned third-party requests for the disclosure of, on the one hand, a clinical study report (CSR) submitted for the MA application for PTC’s Translarna, an ultraorphan drug, and, on the other, five preclinical, toxicology study reports relating to MSD’s veterinary medicine Bravecto. Background.
Expert insights. Personalized for you.
52 
Let's personalize your content